Article Sidebar
Date Published:
26/02/2024
Online Published:
26/02/2024
Abstract Views: 60
Views PDF: 48
Views PDF: 48
Issue
Section
Thông tin cập nhật kiến thức
How to Cite
Le, H. P., Le, T. V., Pham, H. M. Q., Huynh, M. D., Lam, V. H., Duong, L. T. T., & Pham, M. C. (2024). A CASE OF ACUTE LIVER FAILURE DUE TO LIVER METASTASES IMPROVED WITH CHEMOTHERAPY. Cantho Journal of Medicine and Pharmacy, 71, 202-207. https://doi.org/10.58490/ctump.2024i71.2299
A CASE OF ACUTE LIVER FAILURE DUE TO LIVER METASTASES IMPROVED WITH CHEMOTHERAPY
Main Article Content
Abstract
Liver dysfunction due to metastatic liver cancer carries an extremely poor prognosis, making treatment challenging, and most cases result in death within days to weeks. We report a case of severe liver dysfunction due to metastatic cancer that has benefited from chemotherapy. Lesions ceased to progress on imaging, and liver function improved, gradually returning to normal limits. The patient survived an additional 8 months.
Article Details
Keywords
Liver metastases, Severe liver dysfunction, chemotherapy
References
1. Rowbotham D., Wendon J.,Williams R.. Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut. 1998. 42 (4), 576-80, doi: 10.1136/gut.42.4.576.
2. Alexopoulou A., Koskinas J., Deutsch M., et al. Acute liver failure as the initial manifestation of hepatic infiltration by a solid tumor: report of 5 cases and review of the literature. Tumori. 2006. 92 (4), 354-7, doi: 10.1177/030089160609200417.
3. Athanasakis E., Mouloudi E., Prinianakis G., et al. Metastatic liver disease and fulminant hepatic failure: presentation of a case and review of the literature. Eur J Gastroenterol Hepatol. 2003. 15 (11), 1235-40, doi: 10.1097/00042737-200311000-00014.
4. Field K. M., Dow C.,Michael M. Part I: Liver function in oncology: biochemistry and beyond. Lancet Oncol. 2008. 9 (11), 1092-101, doi: 10.1016/S1470-2045(08)70279-1.
5. Giuliani J.,Bonetti A. Acute Liver Failure Caused by Metastatic Breast Cancer: Can We Expect Some Results from Chemotherapy?". Dig Dis Sci. 2015. 60 (8), 2541-3, 10.1007/s10620-015-3741-6.
6. Mogrovejo E., Manickam P., Amin M., et al. Characterization of the syndrome of acute liver failure caused by metastases from breast carcinoma. Dig Dis Sci. 2014. 59 (4), 724-36, doi:
10.1007/s10620-013-2943-z.
7. Wyld L., Gutteridge E., Pinder S. E., et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer. 2003. 89 (2), 284-90, doi: 10.1038/sj.bjc.6601038.
8. Kasi P. M., Thanarajasingam G., Finnes H. D., et al. Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer. Case Rep Oncol Med. 2015. 420159, doi: 10.1155/2015/420159.
9. Superfin D., Iannucci A. A.,Davies A. M. Commentary: Oncologic drugs in patients with organ dysfunction: a summary. Oncologist. 2007. 12 (9), 1070-83, doi: 10.1634/theoncologist.12-9-1070.
10. Goswami R., Babich M.,Farah K. F. Occult breast malignancy masquerading as acute hepatic failure. Gastroenterol Hepatol (N Y). 2011. 7 (1), 62-5, PMCID: PMC3038321.
11. Giuliani J.,Bonetti A. Acute Liver Failure Caused by Metastatic Breast Cancer: Can We Expect Some Results from Chemotherapy?. Dig Dis Sci. 2015. 60 (8), 2541-3, doi: 10.1007/s10620-015-3741-6.
12. Quidde J., Azémar M., Bokemeyer C., et al. Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature. Ther Adv Med Oncol. 2016. 8 (3), 144-52, doi:
10.1177/1758834016637585.
13. Walia T., Quevedo J. F., Hobday T. J., et al, Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy. Ther Clin Risk Manag. 2008. 4 (6), 1363-6, doi: 10.2147/tcrm.s3951.
2. Alexopoulou A., Koskinas J., Deutsch M., et al. Acute liver failure as the initial manifestation of hepatic infiltration by a solid tumor: report of 5 cases and review of the literature. Tumori. 2006. 92 (4), 354-7, doi: 10.1177/030089160609200417.
3. Athanasakis E., Mouloudi E., Prinianakis G., et al. Metastatic liver disease and fulminant hepatic failure: presentation of a case and review of the literature. Eur J Gastroenterol Hepatol. 2003. 15 (11), 1235-40, doi: 10.1097/00042737-200311000-00014.
4. Field K. M., Dow C.,Michael M. Part I: Liver function in oncology: biochemistry and beyond. Lancet Oncol. 2008. 9 (11), 1092-101, doi: 10.1016/S1470-2045(08)70279-1.
5. Giuliani J.,Bonetti A. Acute Liver Failure Caused by Metastatic Breast Cancer: Can We Expect Some Results from Chemotherapy?". Dig Dis Sci. 2015. 60 (8), 2541-3, 10.1007/s10620-015-3741-6.
6. Mogrovejo E., Manickam P., Amin M., et al. Characterization of the syndrome of acute liver failure caused by metastases from breast carcinoma. Dig Dis Sci. 2014. 59 (4), 724-36, doi:
10.1007/s10620-013-2943-z.
7. Wyld L., Gutteridge E., Pinder S. E., et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer. 2003. 89 (2), 284-90, doi: 10.1038/sj.bjc.6601038.
8. Kasi P. M., Thanarajasingam G., Finnes H. D., et al. Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer. Case Rep Oncol Med. 2015. 420159, doi: 10.1155/2015/420159.
9. Superfin D., Iannucci A. A.,Davies A. M. Commentary: Oncologic drugs in patients with organ dysfunction: a summary. Oncologist. 2007. 12 (9), 1070-83, doi: 10.1634/theoncologist.12-9-1070.
10. Goswami R., Babich M.,Farah K. F. Occult breast malignancy masquerading as acute hepatic failure. Gastroenterol Hepatol (N Y). 2011. 7 (1), 62-5, PMCID: PMC3038321.
11. Giuliani J.,Bonetti A. Acute Liver Failure Caused by Metastatic Breast Cancer: Can We Expect Some Results from Chemotherapy?. Dig Dis Sci. 2015. 60 (8), 2541-3, doi: 10.1007/s10620-015-3741-6.
12. Quidde J., Azémar M., Bokemeyer C., et al. Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature. Ther Adv Med Oncol. 2016. 8 (3), 144-52, doi:
10.1177/1758834016637585.
13. Walia T., Quevedo J. F., Hobday T. J., et al, Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy. Ther Clin Risk Manag. 2008. 4 (6), 1363-6, doi: 10.2147/tcrm.s3951.